TED · Award
Cardiovascular & Respiratory Medicines.
A public procurement published by The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") via TED.
TEDAward
- —
- Award value
- £22.1m
- Tender value
- 0
- Suppliers
- 0
- Awards
- 1
- Notices
- Award
- Stage
Key details
- Buyer
- The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
- Source
- TED
- Lifecycle stage
- Award
- Status
- —
- CPV classification
- 33600000
- Currency
- GBP
- Total award value
- —
- Tender value
- £22,123,563
- First published
- 23 Mar 2017
- Last updated
- 23 Mar 2017
Notice timeline
Every published notice in this procurement's lifecycle.
Frameworks & programmes
More from The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Cardiovascular and Respiratory Medicines
Award · TEDENT, Ophthalmology and Skin Medicines/Medical Devices
Tender · TEDOncology Generics Medicines
Award · TEDAntibiotic and Genito Urinary Branded and Generic Medicines
Tender · TEDENT, Ophthalmology and Skin Medicines/Medical Devices
Award · TEDRadiotherapy, Linear Accelerator, for Highland Health Board and Tayside Health Board
Tender · TEDFAQs about this procurement
Who is the buyer for "Cardiovascular & Respiratory Medicines."?
Cardiovascular & Respiratory Medicines. is a UK public-sector procurement published by The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") via TED.
Has "Cardiovascular & Respiratory Medicines." been awarded?
No award has been recorded yet. The current lifecycle stage is "Award".
What is "Cardiovascular & Respiratory Medicines." worth?
The reported tender value is £22,123,563.
When was "Cardiovascular & Respiratory Medicines." published?
It was first published on 23 Mar 2017 and last updated on 23 Mar 2017, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable